Incision-free retinal tear repair
A Canadian surgeon has developed an incision-free technique to seal retinal tears, usually within 24 hours.
Staff reporters1 min read
Advertisement
A Canadian surgeon has developed an incision-free technique to seal retinal tears, usually within 24 hours.
The successful trial of a new stem cell cultivation technique to repair corneal trauma has made its US developers the first to meet the FDA’s strict tissue engineering requirements. Researchers at
The Peter MacCallum Cancer Centre in Victoria is the latest Australasian hospital to offer indoor digital wayfinding for vision-impaired patients, using a new smartphone app developers say has 10-20
An investigation by Australian-based cataract surgeons found: posterior corneal surgically induced astigmatism (SIA) could not be predicted pre-operatively using biometric features; centroid posterior corneal SIA is extremely small (near zero); and no difference in posterior corneal SIA was found wh
The board of Eye Health Aotearoa (EHA) has elected acting chair John Mulka, former CEO of Blind and Low Vision New Zealand, and trustee Chrissie Cowan, CEO of Kāpō Māori Aotearoa, as new co-chairs.
Australia has passed a law restricting the use of the title ‘surgeon’ to specialist surgeons. Prior to the Health Practitioner Regulation National Law (Surgeons) Amendment Bill, any registered
Researchers at Moorfields Eye Hospital and UCL Institute of Ophthalmology have developed an artificial intelligence (AI) system with the potential to identify eye diseases, heart attacks, stroke and
An international study found the neurological pupil index (NPi) is an effective means to evaluate disease progression and predict outcomes for acute brain injury patients. The ‘Orange’ study
Women are three times less likely to be among the first to ask questions at ophthalmology grand rounds (GR) sessions, according to a US study. Researchers led by Dr Lauren Hennein, University of
A US research team said it hopes its new ‘eye atlas’, detailing which eye cell types express certain disease-associated genes, will support the design of effective therapeutic strategies to avoid
One of the most exciting facets of being medical retina specialists is the continued evolution of age-related macular degeneration (AMD) therapies. We have come a long way from the days of
After the challenging Covid years, Macular Degeneration New Zealand (MDNZ) is back and re-engaging with health professionals, offering more learning opportunities from October 2023.